🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, risking penalties, legal action or prison.

Service Reaction and Material Removal

According to the social media company, the service has removed violative content and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also found groups with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

After minutes of joining one group, a seller shared contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.

Item Details and Pricing

Within these groups, messages show black plastic packages with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has already encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to possibly serious medical dangers”.